CSPC Pharma Cash Flow - Annual (OTCMKTS:CHPTY)

Add to My Stocks
$101.08 $0 (0%) CHPTY stock closing price Nov 29, 2017 (Closing)

The CSPC Pharma cash flow statement helps investors understand how well the company is managing its cash flows. While its important to look at the CSPC Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as CSPC Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. This statement can tell if a company is running out of money while still being profitable and is useful in CSPC Pharma stock analysis. CSPC Pharma had a positive net income cash flow of $339.43M for the latest 2016. This report is very useful in measuring the short term viability of a company. CSPC Pharma had an inflow of $375.61M from operating activities, $-58.26M spend due to financing activities, and $-171.51M outflow due to investing activities for 2016.

View details of CSPC Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow75.69M78.07M78.71M84.59M22.27M77.73M73.89M64.78M3.75M
Net Increase (Decrease) in Assets Liabilities28.18M-5.94M-55.44M-95.73M-36.07M-69.37M-56.16M4.87M-19.6M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net-67.69M-54.26M--44.64M-218.57M-2.71M-12.28M-12.65M68.27M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-140.52M-104.01M-102.51M-72.65M-24.37M-98.45M-93.22M-87.32M-44.84M
Acquisition Disposition of Subsidiaires-9.84M4.49M3.26M166.99M90.37M---33.22M-1.98M
Increase (Decrease) in Investments-11.62M6.89M---0.82M---0.21M-4.86M
Other Cash Inflow (Outflow) from Investment Activities-9.51M-3.1M-13.88M-31.44M-16.81M-12.8M-9.74M-4.97M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares72.53M-----2.67M---0.82M
Issuance (Repayment) of Debt Securities-36.43M33.95M---57.96M-4.92M25.04M-
Increase (Decrease) in Bank & Other Borrowings---8.12M-122.14M-9.94M----30.53M
Payment of Dividends & Other Cash Distributions---63.59M-51.75M-52.75M-25.28M-50.44M-39.6M-9.87M
Other Cash from (used by) Financing Activities-94.37M-111.95M-24.62M-49M111.25M25.07M-18.57M-15.61M-12.19M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-25.38M-13.23M-4.35M3.61M-5.76M6.17M-3.35M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year296.17M189.42M153.21M186.9M40.01M141.32M185.73M144.61M55.99M
Cash & Equivalents at Year End416.62M296.63M189.42M153.1M186.9M132.93M141.54M186.16M143.94M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Grifols financial analysis

CSPC Pharma stock price history provides insight into historical stock price fluctuations, and CSPC Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • CSPC Pharma has cash of $416.62M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the CSPC Pharma stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. CSPC Pharma gained $375.61M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-171.51M for CHPTY in last 2016 report.
  • Cash flow from financing activities shows the flow of cash between CSPC Pharma and its owners and creditors and was $-58.26M for 2016. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For CSPC Pharma Cash Flow

FCF margin

Annual Cash Flow Statements For CSPC Pharmaceutical Group Ltd (ADR) Peers

Grifols cash flow, Guangzhou Pharma cash flow, Merck KGAA cash flow, Sagent Pharma cash flow